focus -WSS

focus

author：Wikipedia 2025-10-01 18:23:26 - browse：758

Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a handful of biotech companies are trying to develop next-generation, longer-lasting therapies based on a very different approach: RNA interference.

This Nobel Prize-winning science works by degrading the biological blueprints that RNA use to make proteins — without the genetic instructions, the troublesome proteins are never made and the gene is essentially muted.

If the companies succeed, it would be a significant shift in the obesity treatment revolution, away from weekly drugs targeting hormones to medications that could be given much less frequently — twice a year or even less — and pinpoint genetic contributors to weight.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： 3 hurdles to bringing medical devices to the U.S. market

entertainment

explore

WSS

Akili, maker of video game for ADHD, to be acquired for 34 million

First Opinion Podcast: What happens when kids become caregivers?

Paxlovid study fails to answer questions over benefit for broader groups

Why we need to separate burnout from moral injury in health care

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

WATCH: Why do fingernails fall off when they're damaged?

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

AI used to predict Covid

The high cost of giving birth even with insurance

The science behind Janet Jackson's pregnancy at 49

Hollywood unions extend contract negotiations for actors

The science behind Janet Jackson's pregnancy at 49

Malaria cases in Florida and Texas: Here’s what you need to know

Cloning humans is technically possible. It's curious no one has tried

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Dark money group runs ads on China biotech bill

knowledge

Dark money group runs ads on China biotech bill

The story of mRNA: From a loose idea to a tool that may help curb Covid

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Scientists successfully use ultrasound imaging to map brain activity

Average age of first period drops to 11.9 years, study shows

Latest bird flu infection made farmworker sicker than earlier cases

hotspot

entertainment

explore

focus